Study reveals an increase in adenomas and advanced adenomas in younger adults, alongside a rise in colorectal cancer incidence in males under 50, suggesting a need for earlier screening, particularly in men.
Daily Oral Edaravone for ALS No Better Than On/Off Regimen
SAVANNAH, Ga. — Daily oral edaravone (Radicava ORS) was not superior to the FDA-approved on/off regimen in amyotrophic lateral sclerosis (ALS), a phase IIIb trial
October 22, 2024